1.
2.
Int Forum Allergy Rhinol
; 14(8): 1386-1390, 2024 Aug.
Article
in English
| MEDLINE
| ID: mdl-38616557
ABSTRACT
KEY POINTS: SinoNasal Microbiota Transfer (SNMT) was safe with immediate benefit in all recipients, with sustained improvement in two of three recipients for up to 180 days. The addition of antimicrobial photodynamic therapy worsened chronic rhinosinusitis. These promising SNMT results warrant further study of safety and efficacy.